查看購物車
  • Simplified Chinese
  • English
  • Japanese
體外肺模型市場規模及預測 2021 - 2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按類型、應用、最終用戶及地理分類
市場調查報告書
商品編碼
1761169

體外肺模型市場規模及預測 2021 - 2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：按類型、應用、最終用戶及地理分類

In Vitro Lung Models Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 231 Pages | 訂單完成後即時交付

價格

體外肺模型市場規模預計將從2024年的4.4635億美元增加到2031年的15.3011億美元。預計該市場在2025-2031年期間的複合年成長率將達到19.4%。推動市場成長的主要因素包括呼吸系統疾病盛行率的飆升以及體外模型作為動物試驗替代方案的日益普及。此外，3D培養和人工智慧在腫瘤學中的應用有望在預測期內推動市場發展。然而，缺乏熟練的專業人員是市場發展的限制因素之一。

根據全球慢性阻塞性肺病計劃組織發布的報告，全球約有6500萬人患有阻塞性肺病（COPD），每年近300萬人死於該疾病，是全球第四大致死原因。根據2023年美國肺臟協會的資料，約有3,400萬美國人患有氣喘和COPD等慢性肺部疾病。 2022年，約有1,170萬成年人（占美國人口的4.6％）被診斷出患有COPD。根據2020年《歐洲呼吸雜誌》的一篇文章，據報歐洲有3658萬名COPD患者，預計到2050年將達到4945萬，相對成長35.2％。隨著發展中國家吸菸率的上升和高收入國家人口老化，預計未來四十年COPD的盛行率將上升。根據世界衛生組織 (WHO) 估計，到 2030 年，COPD 將成為全球主要死亡原因之一，預計到 2060 年，每年將有超過 540 萬人死於 COPD 及相關疾病。

因此，呼吸系統疾病正在刺激對先進研究模型的需求，以了解疾病機制並開發有效的治療方法。

體外肺模型，例如精密切割肺切片 (PCLS)，可用於研究氣道收縮和炎症，從而有助於評估氣喘和其他呼吸系統疾病的新型治療標靶。目前已開發出用於複製人體肺部生理狀況的晶片肺裝置。密西根大學的「晶片肺」裝置利用在帶有微通道的塑膠晶片上培養的人體肺組織細胞來模擬肺部內部狀況，為疾病研究提供新的見解。因此，對有效治療和研究模型日益成長的需求推動了體外肺模型市場的成長。

此外，2D (2D) 細胞培養（或單層細胞培養）因其成本效益高、通量高、易於複製和結果解讀等特點，在細胞生物學中被廣泛用於疾病研究和藥物篩選。然而，它們無法複製活體患者腫瘤3D腫瘤微環境 (TME) 中複雜的動態交互作用網路。這限制了它們模擬癌症行為和藥物反應的能力，也限制了它們在2D培養中從患者活體組織切片樣本中分離和維持癌細胞系的能力。傳統的2D細胞培養雖然是基礎技術，但無法複製肺癌體內複雜的TME和細胞交互作用。隨著癌症研究的進展，越來越多的動物被用於創建動物模型。這些動物包括小鼠、大鼠和其他類似物種。然而，動物模型在將臨床前研究發現轉化為有效臨床治療方面的成功率較低；這引發了人們對其作為人體療效預測指標的可靠性的擔憂。為了突破這些局限性，研究正轉向更生理相關的人體體外模型（3D細胞培養模型），例如球狀體、類器官、類腫瘤和微流體系統，這些模型可以更好地模擬臨床觀察到的腫瘤微環境（TME）、基因表現和藥物反應。這些模型對於驗證藥物療效和改進臨床前測試至關重要，尤其是在肺癌研究中。將3D模型整合到藥物篩選對於驗證2D培養結果和評估抗癌藥物的效果至關重要。這些方法已被證明對癌症藥物篩選卓有成效，並正在成為塑造未來肺癌研究和治療發展的關鍵工具。 3D細胞培養模型在肺癌藥理學研究中的應用代表著理解和治療肺部疾病方法的典範轉移。

比較公司分析基於產品組合（產品滿意度、產品特性和可用性）、近期市場發展（併購、新產品發布和改進、投資和融資、獎項、協議、合作與夥伴關係、認可和擴張）以及地理位置，對體外肺模型市場進行評估和分類，以幫助企業更好地做出決策並了解競爭格局。該報告深入探討了全球體外肺模型市場領先供應商近期的重大發展和創新。主要市場參與者包括 MatTek Corp、Lonza Group AG、Emulate, Inc、CN Bio Innovations Ltd、PromoCell GmbH、Charles River Laboratories International Inc、MIMETAS BV、InSphero AG、Organovo Holdings Inc、Draper, Inc、Epithelix、AlveoliX AG 和美國培養物保藏中心 (ATCC)。

根據類型，市場分為 3D 模型和 2D 模型。 2024 年，3D 模型佔據了體外肺模型市場的最大佔有率，預計在 2024-2031 年期間將實現最高的複合年成長率。

3D肺模型能夠精準複製人體肺組織的複雜結構和細胞交互作用。其增強的生理相關性使其在藥物研發、毒性測試和疾病建模中具有不可估量的價值。 3D肺模型的主要類型包括球狀體、類器官和精密切割肺切片（PCLS）。在3D模型中，細胞在3D結構中培養，這比傳統的2D模型更具優勢。這些模型能夠精確複製肺部的結構和微環境，從而能夠精確模擬生理狀況。因此，使用3D模型進行藥物和治療研究往往比基於2D模型或動物模型的結果更準確、更可靠。

根據應用，體外肺模型市場細分為藥物發現和毒理學研究、生理學研究、再生醫學等。 2024年，藥物發現和毒理學研究領域佔據體外肺模型市場的最大佔有率。

根據最終用戶，體外肺模型市場細分為製藥和生物技術公司、學術和研究機構以及其他。製藥和生物技術公司在2024年佔據了體外肺部模型市場的最大佔有率。

體外肺模型市場的公司採用各種有機和無機成長策略。有機成長策略主要包括產品發布和產品批准。市場上常見的無機成長策略包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠拓展業務，增強地域影響力，並促進整體市場成長。此外，收購和夥伴關係等策略有助於鞏固客戶群並擴展產品組合。以下列出了體外肺模型市場主要參與者的一些重要進展。

2024年9月，專注於體外人體組織開發的生物技術公司MatTek Life Sciences宣布將其器官型人體組織授權給位於中國的生命科學實驗室CellEx。此次策略合作標誌著人體組織在研究、藥物開發和安全評估應用方面的進步和應用的里程碑。

2023年6月，下一代體外模型供應商Emulate, Inc.宣布透過早期試用計畫推出Emulate Chip-A1 Accessible Chip。這款全新的器官晶片設計在原有的Chip-S1（透過模擬組織-血管界面，並考慮相關的生物力學力，例如拉伸和流動）的基礎上進行了擴展，允許用戶在上皮培養室內創建更厚的組織，並應用額外的藥物治療方案，包括局部用藥或霧化給藥。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：體外肺模型市場格局

  • 概述
  • PEST分析
  • 監管情景

第5章：體外肺模型市場－關鍵市場動態

  • 體外肺部模型市場－關鍵市場動態
  • 市場促進因素
    • 呼吸系統疾病發生率激增
    • 擴大採用體外模型作為動物試驗的替代方案
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 體外模式資金和投資激增
  • 未來趨勢
    • 3D培養與人工智慧在腫瘤學的應用
  • 促進因素和限制因素的影響：

第6章：體外肺部模型市場-全球市場分析

  • 2021-2031年體外肺模型市場收入
  • 體外肺部模型市場預測分析

第7章：體外肺模型市場分析－依類型

  • 3D模型
  • 2D模型

第 8 章：體外肺部模型市場分析 - 按應用

  • 藥物研發與毒理學研究
  • 生理學研究
  • 再生醫學
  • 其他

第9章：體外肺模型市場分析－依最終用戶

  • 製藥和生物技術公司
  • 學術和研究機構
  • 其他

第 10 章：體外肺部模型市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 概述
  • 新產品開發
  • 合併與收購
  • 夥伴關係與合作
  • 其他商業策略

第 12 章：競爭格局

  • 2024年全球公司市佔率分析

第13章：公司簡介

  • MatTek Corp
  • Lonza Group AG
  • Emulate, Inc.
  • CN Bio Innovations Ltd
  • Merck KGaA
  • PromoCell GmbH
  • Charles River Laboratories International Inc
  • MIMETAS BV
  • InSphero AG
  • Organovo Holdings Inc
  • Draper, Inc.
  • TissUse GmbH
  • Epithelix
  • AlveoliX AG
  • American Type Culture Collection (ATCC)

第 14 章：附錄

Product Code: TIPRE00006695

The In Vitro lung models market size is projected to reach US$ 1,530.11 million by 2031 from US$ 446.35 million in 2024. The market is estimated to register a CAGR of 19.4% during 2025-2031. Major factors driving the market growth include a surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing. Further, Applications of 3D cultures and AI in oncology is likely to boost the market during the forecast period. However, lack of skilled professionals are among the market deterrents.

According to a report published by the Global Initiative on Chronic Obstructive Lung Disease, ~65 million people suffer from obstructive pulmonary disease (COPD), and nearly 3 million people die from the disease each year, making it the fourth leading cause of mortality worldwide. According to the 2023 American Lung Association data, ~34 million Americans were affected by chronic lung diseases such as asthma and COPD. In 2022, ~11.7 million adults, or 4.6% of the population in the US, were diagnosed with COPD. As per an article published in the European Respiratory Journal in 2020, 36.58 million Europeans were reported to have COPD, which is projected to reach 49.45 million by 2050, representing a 35.2% relative increase. With the growing prevalence of smoking in developing countries and the aging population in high-income countries, the COPD prevalence is projected to rise over the next forty years. As per the World Health Organization (WHO) estimates, COPD will become one of the leading causes of death worldwide by 2030, and it is estimated that by 2060, there will be more than 5.4 million deaths yearly due to COPD and related conditions.

Therefore, respiratory diseases is spurring the demand for advanced research models to understand disease mechanisms and develop effective treatments.

In vitro lung models, such as precision-cut lung slices (PCLS), allow the study of airway constriction and inflammation, facilitating the evaluation of novel therapeutic targets for asthma and other respiratory conditions. Lung-on-a-chip devices have been developed to replicate the physiological conditions of the human lung. The University of Michigan's "lung-on-a-chip" device uses human lung-tissue cells cultured on a plastic chip with microscopic channels to simulate the conditions inside the lungs, providing new insights into diseases. Thus, the increasing demand for effective treatments and research models fuels the growth of the in vitro lung model market.

Moreover, two-dimensional (2D) cell cultures, or monolayers, are widely used in cellular biology to study diseases and for drug screening due to their cost-effectiveness, high throughput, easy replication, and results interpretation. However, they fall short in replicating the complex network of dynamic interactions present in the three-dimensional tumor microenvironment (TME) of living patient tumors. This aspect limits their ability to model cancer behavior and drug responses, as well as to isolate and maintain cancer cell lines from patient biopsies in 2D cultures. Traditional 2D cell cultures, while foundational, fall short in replicating the intricate TME and cellular interactions that characterize lung cancers in vivo. As cancer research advances, an increasing number of animals are being utilized in the creation of animal models. These animals include mice, rats, and other similar species. However, animal models exhibit low success rates in translating preclinical findings into effective clinical treatments; this has raised concerns about their reliability as predictors of human responses. To address these limitations, research is shifting toward more physiologically relevant human in vitro models (3D cell culture models)-such as spheroids, organoids, tumoroids, and microfluidic systems-that better mimic the TME, gene expression, and drug responses observed clinically. These models are critical for validating drug efficacy and improving preclinical testing, especially in lung cancer research. Integrating 3D models in drug screening is essential to validate findings from 2D cultures and assess the effects of anticancer drugs. Such approaches have proven to be fruitful for cancer drug screening and are emerging as a pivotal tool in shaping the future of lung cancer research and therapeutic development. The use of 3D cell culture models in lung cancer pharmacology research represents a paradigm shift in the approach toward understanding and treating lung diseases.

The comparative company analysis evaluates and categorizes the in vitro lung models market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global in vitro lung models market. The key market players are MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC).

Based on type, the market is divided into 3D Models and 2D Models. The 3D Models segment held the largest In Vitro Lung Model Market share in 2024, and it is expected to register the highest CAGR during 2024-2031.

3D lung models replicate the complex architecture and cellular interactions of human lung tissue accurately. The enhanced physiological relevance makes them invaluable for drug discovery, toxicity testing, and disease modeling. The primary types of 3D lung models include spheroids, organoids, and precision-cut lung slices (PCLS). In 3D models, cells are cultured within a three-dimensional structure, offering advantages over traditional 2D models. These models closely replicate the architecture and microenvironment of the lung, enabling accurate simulation of physiological conditions. As a result, drug and therapeutic studies using 3D models tend to yield more accurate and reliable results than those derived from 2D models or animal models.

By application, In Vitro Lung Model market is segmented into drug discovery and toxicology studies, physiological research, regenerative medicine, and others. The drug discovery and toxicology studies segment held the largest share of the in vitro lung model market in 2024.

Per end user, In Vitro Lung Model market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the In Vitro lung model market in 2024.

Various organic and inorganic strategies are adopted by companies operating in the in vitro lung models market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the in vitro lung models market are listed below.

In September 2024, MatTek Life Sciences, a biotech company specializing in the development of in vitro human tissues, announced the licensing of its organotypic human tissues to CellEx, a life science laboratory based in China. This strategic collaboration marks a milestone in the advancement and utilization of human tissues for research, pharmaceutical development, and safety assessment applications.

In June 2023, Emulate, Inc., a provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1 Accessible Chip through an early access program. This new Organ-Chip design expands on the original Chip-S1-which models tissue-vascular interfaces with relevant biomechanical forces such as stretch and flow-by allowing users to create thicker tissues within the epithelial culture chamber and apply additional drug treatment options, including topical or aerosolized applications.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. In-Vitro Lung Model Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Regulatory Scenario

5. In-Vitro Lung Model Market - Key Market Dynamics

  • 5.1 In-Vitro Lung Model Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Surging Prevalence of Respiratory Diseases
    • 5.2.2 Rising Adoption of In Vitro Models as an Alternative to Animal Testing
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Surging Funding and Investments for In Vitro Models
  • 5.5 Future Trends
    • 5.5.1 Application of 3D Cultures and AI in Oncology
  • 5.6 Impact of Drivers and Restraints:

6. In-Vitro Lung Model Market - Global Market Analysis

  • 6.1 In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • 6.2 In-Vitro Lung Model Market Forecast Analysis

7. In-Vitro Lung Model Market Analysis - by Type

  • 7.1 3D Model
    • 7.1.1 Overview
    • 7.1.2 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 2D Model
    • 7.2.1 Overview
    • 7.2.2 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

8. In-Vitro Lung Model Market Analysis - by Application

  • 8.1 Drug Discovery and Toxicology Studies
    • 8.1.1 Overview
    • 8.1.2 Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Physiological Research
    • 8.2.1 Overview
    • 8.2.2 Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

9. In-Vitro Lung Model Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Academic and Research Institutes
    • 9.2.1 Overview
    • 9.2.2 Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

10. In-Vitro Lung Model Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America In-Vitro Lung Model Market Overview
    • 10.2.2 North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.2.3.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.4.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.5.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.2.2 United States: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.2.3 United States: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.6.3 Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.3.2 Canada: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.6.4 Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.4.2 Mexico: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: In-Vitro Lung Model Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe In-Vitro Lung Model Market Overview
    • 10.3.2 Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: In-Vitro Lung Model Market Breakdown, by Type
      • 10.3.3.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: In-Vitro Lung Model Market Breakdown, by Application
      • 10.3.4.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.5.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.2.2 Germany: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.2.3 Germany: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.3 France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 France: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.3.2 France: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.3.3 France: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.4 United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 United Kingdom: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.4.2 United Kingdom: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.4.3 United Kingdom: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.5 Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.5.2 Italy: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.5.3 Italy: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.6 Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.6.2 Spain: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.6.3 Spain: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.7.2 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: In-Vitro Lung Model Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific In-Vitro Lung Model Market Overview
    • 10.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
      • 10.4.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.4.5 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.2 China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.2.1 China: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.2.2 China: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.2.3 China: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.3 Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.3.1 Japan: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.3.2 Japan: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.3.3 Japan: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.4 India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.4.1 India: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.4.2 India: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.4.3 India: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.5 South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.5.1 South Korea: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.5.2 South Korea: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.5.3 South Korea: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.6 Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.6.1 Australia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.6.2 Australia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.6.3 Australia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.7 Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.7.1 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.7.2 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.7.3 Rest of APAC: In-Vitro Lung Model Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa In-Vitro Lung Model Market Overview
    • 10.5.2 Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.2.2 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.3 South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.3.2 South Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.4.2 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.5.2 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America In-Vitro Lung Model Market Overview
    • 10.6.2 South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.6.3.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.6.4.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.5.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.2.2 Brazil: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.3 Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.3.2 Argentina: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.4.2 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 New Product Development
  • 11.3 Merger and Acquisition
  • 11.4 Partnerships and Collaborations
  • 11.5 Other Business Strategies

12. Competitive Landscape

  • 12.1 Global Company Market Share Analysis, 2024

13. Company Profiles

  • 13.1 MatTek Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Lonza Group AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Emulate, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 CN Bio Innovations Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Merck KGaA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 PromoCell GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
  • 13.7 Charles River Laboratories International Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 MIMETAS BV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Organovo Holdings Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Draper, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 TissUse GmbH
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
  • 13.13 Epithelix
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Financial Overview
    • 13.13.4 SWOT Analysis
    • 13.13.5 Key Developments
  • 13.14 AlveoliX AG
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 American Type Culture Collection (ATCC)
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. In-Vitro Lung Model Market Segmentation
  • Table 2. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 5. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 6. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 11. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 12. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 19. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 20. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 25. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 26. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 29. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 30. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 31. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 32. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 33. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 34. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 35. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 36. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 37. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 38. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 39. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 40. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 41. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 42. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 43. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 44. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 45. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 46. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 49. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 50. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 51. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 52. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 53. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 54. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 55. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 56. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 57. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 58. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 59. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 61. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 62. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 65. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 66. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 67. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 68. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 69. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 70. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 73. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 74. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 77. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 78. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 79. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 80. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 81. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 82. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 83. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 84. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 85. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 86. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 87. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 88. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 89. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 90. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 93. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 94. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 95. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 96. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 97. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 98. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 99. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 100. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 101. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 102. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 105. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 106. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 109. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 110. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 111. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 112. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 113. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 114. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 115. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 116. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 117. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 118. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 119. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 120. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 121. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 122. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 123. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 124. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 127. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 128. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 129. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 130. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 131. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 132. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 133. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 134. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 135. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 136. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 137. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 138. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 139. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 140. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 141. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 142. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 143. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 144. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 145. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 146. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 147. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 148. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 149. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 150. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 151. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 152. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 155. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 156. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 157. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 158. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 159. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 160. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 161. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 162. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 163. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 164. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 165. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 166. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 167. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 168. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 169. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 170. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 171. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 172. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 173. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 174. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 175. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 176. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 177. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 178. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. Glossary of Terms, In-Vitro Lung Model Market

List Of Figures

  • Figure 1. In-Vitro Lung Model Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • Figure 5. In-Vitro Lung Model Market Share (%) - by Type (2024 and 2031)
  • Figure 6. 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. In-Vitro Lung Model Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. In-Vitro Lung Model Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. In-Vitro Lung Model Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 20. North America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 28. Europe: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 39. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 41. China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 49. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 50. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 51. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 58. South and Central America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 59. South and Central America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 60. South and Central America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 61. Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Global Company Market Share Analysis, 2024